Progress Reports in the Battle against Acquired Immune Deficiency Syndrome

FDA Consumer, February 1989 | Go to article overview

Progress Reports in the Battle against Acquired Immune Deficiency Syndrome


Progress Reports in the Battle Against Acquired Immune Deficiency Syndrome

Inspections Find 1 of 9 Blood Banks Deficient

A year-long inspection program by FDA of the nation's blood and plasma collection centers led to 39 recalls of blood and blood components last year and an agreement by the nation's largest blood distributor, the American Red Cross, to tighten its operations.

From October 1987 through September 1988, FDA reviewed the records of 2,424 blood banks and plasmapheresis centers and found that 278, or 11 percent, were delinquent to some degree in following the agency's regulations for handling blood components. Thirty-nine of the inspections led to voluntary recalls, but no confirmed AIDS-contaminated blood was transfused. Most of the recalls were for human and computer errors involving, for example, incomplete testing procedures, distribution of some units that initially tested positive for the hepatitis B virus, and collection from unsuitable donors. FDA notified the centers of needed corrections.

FDA's routine inspections of these facilities had been intensified following several recalls of blood and blood plasma in March 1988 because of possible AIDS and hepatitis contamination. In an April 7 letter sent to all blood bank directors, FDA Commissioner Frank E. Young asked blood banks to review their operating procedures and improve their standards for computerization.

On Sept. 14, FDA signed an agreement with the American Red Cross, which handles approximately half of the 18 million units of blood products distributed each year. The Red Cross agreed to modify its operations to tighten control between its regions and national headquarters, improve its training and auditing, and analyze and redesign computer systems to ensure that unsuitable products are not released or transfused. FDA is working with other centers to improve their procedures as well.

FDA,s inspection program will continue to focus on procedures for donor screening, testing for hepatitis and AIDS virus antibodies, and for quarantining and destroying unsuitable blood products.

New AIDS Programs Passed by Congress

Legislation passed at the end of the 100th Congress provides for several new federal AIDS programs. Part of the Health Omnibus Programs Extensions of 1988 signed by President Reagan Nov. 4, the law authorizes 780 new positions in the Public Health Service over the next two years for AIDS activities.

It also establishes the National Commission on AIDS to, among other things, evaluate clinical studies of AIDS therapies and recommend ways to streamline FDA procedures for approving new drugs and devices and for releasing experimental drugs. The legislation also authorizes the National Institutes of Health, after consulting with FDA, to provide grants and contracts to community groups to conduct clinical studies of AIDS treatments.

Among its other provisions, the law requires that the Department of Health and Human Services: . evaluate the effectiveness and risks of unapproved drugs being used by AIDS patients; . set up a data bank that would include a registry of clinical trials and other information on experimental AIDS drugs; . encourage manufacturers of drugs potentially effective against AIDS to apply for investigational exemptions from FDA (so the drugs could be more widely available to patients)--HHS could provide technical assistance through grants or contracts to manufacturers, researchers and doctors; and . conduct research and education regarding AIDS and blood donations and transfusions.

The law also requires that grant programs for treating AIDS provide patients with information and counseling about both FDA-approved and unapproved therapies. Further, the National Institute of Allergy and Infectious Diseases, after consulting with FDA, is directed to establish an AIDS clinical research review committee to advise on appropriate AIDS research, including drug development. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Progress Reports in the Battle against Acquired Immune Deficiency Syndrome
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.